dehydroepiandrosterone sulfate has been researched along with Cholangiitis, Sclerosing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozłowska-Petriczko, K; Kruk, B; Milkiewicz, P; Wójcicki, M; Wronka, KM; Wunsch, E | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Dehydroepiandrosterone sulfate indicates decreased sulfation capacity and impaired quality of life in patients with primary sclerosing cholangitis.
Topics: Biomarkers; Cholangitis, Sclerosing; Dehydroepiandrosterone Sulfate; Humans; Liver; Quality of Life | 2021 |